Previous Article | Next Article 
Journal of Virology, November 1999, p. 9604-9608, Vol. 73, No. 11
Immunology Division and Division of Molecular Virology,
Received 3 May 1999/Accepted 21 July 1999
Three hypervariable regions were identified in a central portion of
open reading frame 1 of TT virus DNA, which codes for a putative capsid
protein of 770 amino acids. TT virus circulates as quasispecies, with
many amino acid substitutions in hypervariable regions, to evade immune
surveillance of the hosts and to establish a persistent infection.
Late in 1997, a nonenveloped,
single-stranded DNA virus was recovered from a patient, who developed
posttransfusion hepatitis not related to any of the known hepatitis
viruses (non-A through non-G), and named TT virus (TTV) (14,
17). Because TTV has a circular genomic structure (9, 10,
20), it is classified tentatively in the Circoviridae
family (6). Despite being a DNA virus, TTV has an extremely
wide sequence divergence which causes it to fall into at least 16 genotypes separated by an evolutionary distance >0.30 (4, 10, 11,
13, 17-20, 22, 25-27).
TTV may have a hypervariable region (HVR), because amino acid
substitutions among distinct TTV strains of the same genotype are found
more frequently in a central portion of open reading frame 1 (ORF1)
than in the other genomic regions (10, 24). For further
defining the HVR of TTV, the amino acid sequences of the two ORFs (ORF1
and ORF2) of nine TTV isolates of genotype 1a, including three newly
sequenced and six previously reported (10, 17, 24), were
compared. Furthermore, HVR sequences were compared among the many TTV
clones recovered from the sera of five individuals with chronic or
acute TTV infection. The quasispecies nature of circulating TTV may
help it evade immune surveillance and establish persistent infection,
as is seen for hepatitis C virus (HCV) and human immunodeficiency virus
type 1 (2, 7, 8, 16, 29).
HVRs in ORF1 of TTV.
Two patients (TRM1, with HCV-associated
hepatocellular carcinoma, and TK16, with non-A through non-G acute
hepatitis) and one blood donor (TP1-3) were infected with TTV of
genotype 1a. TTV DNAs in their plasma were sequenced (3,308 nucleotides
[nt] corresponding to >85% of the genomic sequence) by a
long-distance PCR method for amplifying 3.4 kb (19). The
sequences were compared with the sequences of six reported isolates of
the same genotype (10, 17, 24) within various genomic regions.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Quasispecies of TT Virus (TTV) with Sequence Divergence in
Hypervariable Regions of the Capsid Protein in Chronic TTV
Infection
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
View larger version (32K):
[in a new window]
FIG. 1.
Genomic organization of TTV and positions of the three
HVRs in ORF1. The genomic organization of the prototype TTV isolate of
genotype 1a (TA278), consisting of 3,853 nt (17, 20), is
shown, with the positions of the two ORFs indicated by arrows. The
positions of HVR1 (nt 1411 to 1476 [aa 275 to 296]), HVR2 (nt 1528 to
1668 [aa 314 to 360]), and HVR3 (nt 1702 to 1794 [aa 372 to 402])
are indicated by black bars in ORF1. A nucleotide sequence including
the HVRs was amplified by PCR with heminested primers with products
indicated at the bottom. The position of the N22 clone (14),
from which primers for detection and genotyping of TTV DNA are deduced
(18, 19), is indicated.
TABLE 1.
Comparison of nucleotide and amino acid sequences within
the HVRs and the remaining regions in ORF1 between the TRM1 isolate
and the other eight isolates of the same genotype (1a)
Sequence divergence in HVRs of TTV clones from patients with chronic TTV infection (C1 and C2) and its evolution with time. Sequential sera were obtained from two patients with non-A through non-G chronic hepatitis complicated by cirrhosis (C1 and C2), both of whom were persistently infected with TTV. C1 had received transfusions during a hysterectomy at the age of 44, and was diagnosed with cirrhosis at 52 years of age. TTV DNA was recovered from serum samples taken at 60, 64, and 68 years of age. C2 was diagnosed with cirrhosis at the age of 74. TTV DNA was recovered from serum samples taken at 79 and 81 years of age.
An 849-bp sequence in ORF1 bearing HVRs (Fig. 1) was amplified by PCR in the presence of TaKaRa Ex Taq (TaKaRa Shuzo Co., Shiga, Japan) with heminested primers. The first-round PCR was performed with NG161 (sense, 5'-GCA ACC GCA GCG GAT ATG CAA TAT CCG TTC-3' [nt 1321 to 1350]) and NG063 (antisense, 5'-CTG GCA TTT TAC CAT TTC CAA AGT T-3' [nt 2161 to 2185]) for 35 cycles, and the second-round PCR was done for 25 cycles with NG152 (sense, 5'-TGC AAT ATC CGT TCG GCT CAC CAC-3' [nt 1337 to 1360]) and NG063. The conditions for both PCR methods were: 94°C, 30 s; 60°C, 30 s; 72°C, 60 s (with an additional 7 min for the last cycle). The amplification products by the first-round PCR measured 865 bp, and those by the second-round PCR measured 849 bp. Products of the second-round PCR were inserted into pT7BlueT-Vector, and the independent TTV clones thus obtained were confirmed to belong to genotype 1a by PCR with primers specific for this genotype, i.e., NG164 (sense, 5'-GGA TAT GTA GAA TTT TGT GCA-3' [nt 2020 to 2040]) and NG165 (antisense, 5'-AAA GCC TTT TGT GGG GTC TG-3' [nt 2126 to 2145]). The obtained clones were sequenced with the BigDye Terminator Cycle Sequence Ready Reaction Kit (PE Applied Biosystems, Foster City, Calif.). Sequence analysis of TTV clones was performed with Genetyx-Mac version 10.1 (Software Development Co., Tokyo, Japan) and ODEN program version 1.1.1 (5) of DDBJ (DNA Data Bank of Japan, National Institute of Genetics, Mishima, Japan). Ten TTV clones from C1 at year 0 revealed quasispecies with marked sequence divergence in the HVRs, similar to those at years 3.5 and 7.5 (Fig. 2a). The sequences of TTV clones at year 0 was somewhat similar to those at year 3.5; such a similarity was observed also between TTV clones at years 3.5 and 7.5. Ten TTV clones from C2 also showed remarkable heterogeneity in HVR sequences from both testings (Fig. 2b). There was a close relationship between clones obtained at years 0 and 3.3 from C2, which would reflect continuous evolution in the HVR sequence.
|
Sequence of HVRs in TTV clones from three patients with acute TTV infection (A1, A2, and A3). Sera were obtained from two patients with posttransfusion non-A through non-G hepatitis associated with acute TTV infection (14), 10 and 8 weeks after they received transfusions, respectively. An additional serum sample was obtained from one patient with HCV-associated hepatocellular carcinoma 6 weeks after he contracted sporadic TTV infection. His transaminase levels did not change during the 8 weeks that TTV DNA was detected in his serum. All three patients with acute infection lost TTV DNA from their serum by 2 to 7 weeks after the time of testing.
The sequences of the HVRs of 10 TTV clones obtained from each of the patients' sera are shown in Fig. 2c; they were recovered from unfractionated sera (Table 2). In sharp contrast to the marked sequence divergence in TTV clones from the patients with chronic infection, the 10 clones from the three patients with acute infection were strikingly homogeneous in the HVR amino acid sequences.
|
TTV complexed with IgG in sera from patients with chronic infection. TTV particles in sera were immunoprecipitated with ICN/CAPPEL goat antiserum to human immunoglobulin G (IgG) (whole molecule) (ICN Biomedicals, Aurora, Ohio), and supernatant was separated from precipitate (28). They were tested for TTV DNA by PCR (Table 2). Samples were judged to contain TTV complexed with IgG when precipitate generated a higher density of amplification products than supernatant after treatment with goat antiserum to human IgG and when no significant amplification signals were observed in the precipitate fraction after treatment with normal goat serum (ICN Biochemicals).
TTV DNA was detected only in the precipitate fraction of sera from two patients with chronic infection taken at different time points (Table 2). In view of the sensitivity of this experiment, TTV particles in the supernatant were deduced to be less than 1/10 to 1/100 of those in the precipitate for these two patients, with serum titers at 103 to 104 copies/ml. By contrast, TTV particles were detected in supernatant fractions from all three patients with acute infection. Two patients (A1 and A3) were tested when they had peak TTV DNA titers, and their sera had higher TTV DNA titers in precipitate than supernatant. Serum of the remaining patient (A2) taken 3 weeks earlier than the peak TTV DNA level, however, possessed a much higher TTV DNA titer in supernatant than precipitate.Discussion. The Circoviridae family consists of nonenveloped, single-stranded circular DNA viruses (6); there have been only three animal circoviruses known, i.e., chicken anemia virus, beak and feather disease virus of parrots, and porcine circovirus (1, 6, 12, 15). Due to its circular genomic structure (9, 10, 20), TTV may qualify as a fourth animal circovirus, although its genomic size (3,818 to 3,853 nt, depending on genotype) is much larger than those of the other three (1,758 to 2,319 nt) (1, 12, 15, 20).
In spite of being a DNA virus, TTV has an extremely high level of sequence divergence, ranging to 60.5% for the entire genome (20); at least 16 genotypes that differ by >30% from one another have been distinguished (19). The reason for the outstanding genetic heterogeneity of TTV is not clear. The replication of TTV might involve reverse transcription, making for an accelerated mutation rate as is the case for hepatitis B virus (23), a double-stranded DNA virus encoding a reverse transcriptase; a sequence motif for reverse transcriptase has not been identified in the TTV genome, however. Nucleotide sequences vary considerably even among TTV isolates of the same genotype. Sequence divergence resulting in amino acid conversions is the highest in a central portion of ORF1 (10, 24), the translation product of which has an arginine-rich sequence in the N terminus. By analogy with VP1 of chicken anemia virus, which also has this sequence (1, 15), the ORF1 in TTV may encode a capsid protein. Comparison of nine TTV isolates of genotype 1a highlighted three regions in ORF1 that had a markedly divergent amino acid sequence (Fig. 1). They were designated HVR1, HVR2, and HVR3 and coded for 22, 47, and 31 aa, respectively. The nine TTV isolates of genotypes 1a were 92 to 96% similar in the amino acid sequence of the ORF1 product. Most amino acid substitutions in ORF1 (47 to 86%) clustered in HVRs that spanned 100 aa altogether; regions outside HVRs in ORF1 were well conserved, with a similarity of
98%. HVRs in TTV are comparable to the HVR in chicken anemia virus,
which stretches for 13 aa (position, 139 to 151) in the 450-aa VP1
(21).
In individuals with chronic infection, TTV circulates as
quasispecies, with sequence divergence in the HVR. TTV evolves in hosts
by changing its HVR sequences to escape immune surveillance. The
adaptability of the HVR for viral persistence has been well established
for HCV and human immunodeficiency virus type 1 (2, 7, 8, 16,
29). Quasispecies of TTV due to variation in the HVR were found
restricted to hosts with chronic infection. Circulating TTV in hosts
with acute resolving infection, rarely, if ever, showed sequence
divergence in the HVR (Fig. 2).
Should variation in HVR reflect a strategy of TTV to evade immune
surveillance of hosts, humoral antibodies to HVR sequences may well be
present in the circulation. Antibodies to HVR sequences would bind with
circulating TTV to form immune complexes, as is seen in chronic HCV
infection (3). This was actually the case for TTV (Table 2).
In individuals with chronic TTV infection, by far the most TTV
particles in serum were precipitated with goat anti-human IgG, thereby
indicating that they would form immune complexes in the
circulation. In individuals with acute resolving infection, by
contrast, free TTV particles uncomplexed with IgG always
occurred, in amounts exceeding those of complexed TTV in some instances.
Nucleotide sequence accession numbers. The nucleotide sequence data in this report have been deposited in the DDBJ/EMBL/GenBank nucleotide sequence databases under accession no. AB026345 to AB026347 for 3,308 nt of TRM1, TK16, and TP1-3 and AB026348 to AB026427 for 80 TTV isolates consisting of 800 nt covering the HVRs.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Minamikawachi-Machi, Tochigi-Ken 329-0498, Japan. Phone: 81-285-58-7404. Fax: 81-285-44-1557. E-mail: immundiv{at}jichi.ac.jp.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. |
Claessens, J. A.,
C. C. Schrier,
A. P. Mockett,
E. H. Jagt, and P. J. Sondermeijer.
1991.
Molecular cloning and sequence analysis of the genome of chicken anaemia agent.
J. Gen. Virol.
72:2003-2006 |
| 2. | Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, and K. Shimotohno. 1991. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun. 175:220-228[Medline]. |
| 3. |
Hijikata, M.,
Y. K. Shimizu,
H. Kato,
A. Iwamoto,
J. W. Shih,
H. J. Alter,
R. H. Purcell, and H. Yoshikura.
1993.
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.
J. Virol.
67:1953-1958 |
| 4. | Hohne, M., T. Berg, A. R. Muller, and E. Schreier. 1998. Detection of sequences of TT virus, a novel DNA virus, in German patients. J. Gen. Virol. 79:2761-2764[Abstract]. |
| 5. |
Ina, Y.
1994.
ODEN: a program package for molecular evolutionary analysis and database search of DNA and amino acid sequences.
Comput. Appl. Biosci.
10:11-12 |
| 6. | Lukert, P. D., G. F. de Boer, J. L. Dale, P. Keese, M. S. McNulty, J. W. Randers, and I. Tisher. 1995. Family Circoviridae, p. 166-168. In F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.), Virus taxonomy. Classification and nomenclature of viruses, sixth report of the International Committee on Taxonomy of Viruses. Springer, New York, N.Y. |
| 7. |
Martell, M.,
J. I. Esteban,
J. Quer,
J. Genesca,
A. Weiner,
R. Esteban,
J. Guardia, and J. Gomez.
1992.
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.
J. Virol.
66:3225-3229 |
| 8. | Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, L. Morfeldt-Manson, B. Asjo, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910[Medline]. |
| 9. |
Miyata, H.,
H. Tsunoda,
A. Kazi,
A. Yamada,
M. A. Khan,
J. Murakami,
T. Kamahora,
K. Shiraki, and S. Hino.
1999.
Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus.
J. Virol.
73:3582-3586 |
| 10. |
Mushahwar, I. K.,
J. C. Erker,
A. S. Muerhoff,
T. P. Leary,
J. N. Simons,
L. G. Birkenmeyer,
M. L. Chalmers,
T. J. Pilot-Matias, and S. M. Dexai.
1999.
Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans.
Proc. Natl. Acad. Sci. USA
96:3177-3182 |
| 11. | Naoumov, N. V., E. P. Petrova, M. G. Thomas, and R. Williams. 1998. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 352:195-197[Medline]. |
| 12. | Niagro, F. D., A. N. Forsthoefel, R. P. Lawther, L. Kamalanathan, B. W. Ritchie, K. S. Latimer, and P. D. Lukert. 1998. Beak and feather disease virus and porcine circovirus genomes: intermediates between the geminiviruses and plant circoviruses. Arch. Virol. 143:1723-1744[Medline]. |
| 13. | Niel, C., J. M. de Oliveira, R. S. Ross, S. A. Gomes, M. Roggendorf, and S. Viazov. 1999. High prevalence of TT virus infection in Brazilian blood donors. J. Med. Virol. 57:259-263[Medline]. |
| 14. | Nishizawa, T., H. Okamoto, K. Konishi, H. Yoshizawa, Y. Miyakawa, and M. Mayumi. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 241:92-97[Medline]. |
| 15. |
Noteborn, M. H.,
G. F. de Boer,
D. J. van Roozelaar,
C. Karreman,
O. Kranenburg,
J. G. Vos,
S. H. Jeurissen,
R. C. Hoeben,
A. Zantema,
G. Koch,
H. van Ormondt, and A. J. van der Eb.
1991.
Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle.
J. Virol.
65:3131-3139 |
| 16. | Okada, S., Y. Akahane, H. Suzuki, H. Okamoto, and S. Mishiro. 1992. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619-624[Medline]. |
| 17. | Okamoto, H., T. Nishizawa, N. Kato, M. Ukita, H. Ikeda, H. Iizuka, Y. Miyakawa, and M. Mayumi. 1998. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol. Res. 10:1-16. |
| 18. | Okamoto, H., Y. Akahane, M. Ukita, M. Fukuda, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1998. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J. Med. Virol. 56:128-132[Medline]. |
| 19. | Okamoto, H., M. Takahashi, T. Nishizawa, M. Ukita, M. Fukuda, Y. Miyakawa, and M. Mayumi. 1999. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology 259:428-436[Medline]. |
| 20. | Okamoto, H., T. Nishizawa, M. Ukita, M. Takahashi, M. Fukuda, H. Iizuka, Y. Miyakawa, and M. Mayumi. 1999. The entire nucleotide sequence of a TT virus isolate from the United States (TUS01): comparison with reported isolates and phylogenetic analysis. Virology 259:437-448[Medline]. |
| 21. | Renshaw, R. W., C. Soine, T. Weinkle, P. H. O'Connell, K. Ohashi, S. Watson, B. Lucio, S. Harrington, and K. A. Schat. 1996. A hypervariable region in VP1 of chicken infectious anemia virus mediates rate of spread and cell tropism in tissue culture. J. Virol. 70:8872-8878[Abstract]. |
| 22. | Simmonds, P., F. Davidson, C. Lycett, L. E. Prescott, D. M. MacDonald, J. Ellender, P. L. Yap, C. A. Ludlam, G. H. Haydon, J. Gillon, and L. M. Jarvis. 1998. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 352:191-195[Medline]. |
| 23. | Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415[Medline]. |
| 24. | Takahashi, K., Y. Ohta, and S. Mishiro. 1998. Partial -2.4-kb sequences of TT virus (TTV) genome from eight Japanese isolates: diagnostic and phylogenetic implications. Hepatol. Res. 10:110-120. |
| 25. | Tanaka, H., H. Okamoto, P. Luengrojanakul, T. Chainuvati, F. Tsuda, T. Tanaka, Y. Miyakawa, and M. Mayumi. 1998. Infection with an unenveloped DNA virus (TTV) associated with posttransfusion non-A to G hepatitis in hepatitis patients and healthy blood donors in Thailand. J. Med. Virol. 56:234-238[Medline]. |
| 26. | Tanaka, Y., M. Mizokami, E. Orito, T. Nakano, T. Kato, X. Ding, T. Ohno, R. Ueda, S. Sonoda, K. Tajima, T. Miura, and M. Hayami. 1999. A new genotype of TT virus (TTV) infection among Colombian native Indians. J. Med. Virol. 57:264-268[Medline]. |
| 27. | Tanaka, Y., M. Mizokami, E. Orito, T. Ohno, T. Nakano, T. Kato, H. Kato, M. Mukaide, Y. M. Park, B. S. Kim, and R. Ueda. 1998. New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett. 437:201-206[Medline]. |
| 28. | Tsuda, F., H. Okamoto, M. Ukita, T. Tanaka, Y. Akahane, K. Konishi, H. Yoshizawa, Y. Miyakawa, and M. Mayumi. 1999. Determination of antibodies to TT virus (TTV) and application to blood donors and patients with post-transfusion non-A to G hepatitis in Japan. J. Virol. Methods 77:199-206[Medline]. |
| 29. | Weiner, A. J., M. J. Brauer, J. Rosenblatt, K. H. Richman, J. Tung, K. Crawford, F. Bonino, G. Saracco, Q. L. Choo, M. Houghton, and J. H. Han. 1991. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-848[Medline]. |
Journal of Virology, November 1999, p. 9604-9608, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ng, T. F. F., Manire, C., Borrowman, K., Langer, T., Ehrhart, L., Breitbart, M.
(2009). Discovery of a Novel Single-Stranded DNA Virus from a Sea Turtle Fibropapilloma by Using Viral Metagenomics. J. Virol.
83: 2500-2509
[Abstract] [Full Text] -
Leppik, L., Gunst, K., Lehtinen, M., Dillner, J., Streker, K., de Villiers, E.-M.
(2007). In Vivo and In Vitro Intragenomic Rearrangement of TT Viruses. J. Virol.
81: 9346-9356
[Abstract] [Full Text] -
Jelcic, I., Hotz-Wagenblatt, A., Hunziker, A., zur Hausen, H., de Villiers, E.-M.
(2004). Isolation of Multiple TT Virus Genotypes from Spleen Biopsy Tissue from a Hodgkin's Disease Patient: Genome Reorganization and Diversity in the Hypervariable Region. J. Virol.
78: 7498-7507
[Abstract] [Full Text] -
Kakkola, L., Hedman, K., Vanrobaeys, H., Hedman, L., Soderlund-Venermo, M.
(2002). Cloning and sequencing of TT virus genotype 6 and expression of antigenic open reading frame 2 proteins. J. Gen. Virol.
83: 979-990
[Abstract] [Full Text] -
Yokoyama, H., Yasuda, J., Okamoto, H., Iwakura, Y.
(2002). Pathological changes of renal epithelial cells in mice transgenic for the TT virus ORF1 gene. J. Gen. Virol.
83: 141-150
[Abstract] [Full Text] -
Maggi, F., Pistello, M., Vatteroni, M., Presciuttini, S., Marchi, S., Isola, P., Fornai, C., Fagnani, S., Andreoli, E., Antonelli, G., Bendinelli, M.
(2001). Dynamics of Persistent TT Virus Infection, as Determined in Patients Treated with Alpha Interferon for Concomitant Hepatitis C Virus Infection. J. Virol.
75: 11999-12004
[Abstract] [Full Text] -
Bendinelli, M., Pistello, M., Maggi, F., Fornai, C., Freer, G., Vatteroni, M. L.
(2001). Molecular Properties, Biology, and Clinical Implications of TT Virus, a Recently Identified Widespread Infectious Agent of Humans. Clin. Microbiol. Rev.
14: 98-113
[Abstract] [Full Text] -
Ott, C., Duret, L., Chemin, I., Trépo, C., Mandrand, B., Komurian-Pradel, F.
(2000). Use of a TT virus ORF1 recombinant protein to detect anti-TT virus antibodies in human sera. J. Gen. Virol.
81: 2949-2958
[Abstract] [Full Text] -
Hallett, R. L., Clewley, J. P., Bobet, F., McKiernan, P. J., Teo, C. G.
(2000). Characterization of a highly divergent TT virus genome. J. Gen. Virol.
81: 2273-2279
[Abstract] [Full Text] -
Worobey, M.
(2000). Extensive Homologous Recombination among Widely Divergent TT Viruses. J. Virol.
74: 7666-7670
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»